PH2S108 - Planning a Validation Strategy 01 Jan 2022 - 31 Aug 2028 | Version 1

Associated Module Information

Module Code: PH2S108
Module Title: Planning a Validation Strategy
Faculty: Faculty of Computing, Engineering and Science
Faculty Group: Applied Sciences
Faculty Sub Group: Chemistry and Pharmaceutical Science
Module Leader: Suzanna Kean
Module Team:
First Intended Intake: Final Year of Intake:
Date Closed:
Credit Value: 20 Credit Level: 5
Language: English
Percentage of Module Taught in Welsh: 0
Equivalent Module:
HECOS codes: 100078 - business and management 100144 - pharmaceutical engineering
HECOS Code Weighting: 50 50

Document Version Information

Version 1
Valid From 01 Jan 2022
Valid To 31 Aug 2028

Module Aims

The aim of this module is to give students a broad understanding of the elements involved in planning a Validation Strategy from developing a Validation Master Plan (VMP) to preparing a process validation protocol for a validated process

Content Summary

Indicative Syllabus:

• Overview of Regulatory updates with respect to Validation
• The process validation development studies: determining the critical process parameters and quality attributes, and establishing the operational specifications
• Risk management during validation planning, and the role of ICH guidelines Q8, Q9 and Q10
• The quality plan, auditing the suppliers and vendors and their quality plans and documentation, change control, periodic reviews and ongoing quality assessments
• Preparing the product validation strategy and the validation master plan.
• Preparing the cleaning validation protocol and report.
• Health and safety considerations of the interface between the operator and the process
• The validation plan summary report
• The process validation protocol

This module is delivered through open/distance learning resource packs, pre-recorded lectures, problem-solving exercises and case studies.

Learning and Teaching Methods

Activity Type Hours
Independent Study 100
Directed Study 64
Formative Assessment - Independent 36
Total Hours Selected 200

Learning Outcomes

# Learning Outcome
LO1 Understand current regulatory guidance with respect to Validation and preparation for the regulatory audit
LO2 Develop a validation strategy for the entire lifecycle of a product for presentation to regulatory audits.
LO3 Identify the critical process parameters and quality attributes for a validated process and prepare the process validation protocol.

Module Requisites

N/A

Assessment Criteria

Assessment Category Assessment Type Description Duration Word Count Weight (%) Best of? Pass Mark
Asynchronous Assessment Report 1 Based on a case study, generate a protocol for a validated process 0 2100 70 No 40
Asynchronous Assessment Literature/book/paper review 1 Write a review of a report and how it compares to current industry practice 0 1800 30 No 40

Assessment Matrix

Assessment Type Learning Outcomes
LO1 LO2 LO3
Report 1
Literature/book/paper review 1

Reading List

Open distance/learning pack of materials resources

International Conference on Harmonisation (ICH) guidelines Q8, Q9, Q10, Q11

United States code of federal regulations online (www.fda.gov)

EU cGMPs Eudralex collection online ( http://pharmacos.eudra.org/F2/eudralex/vol-4/home.htm )

Pharmaceutical Inspection Convention / Co-operation Scheme (PIC/S) suite of regulatory guidelines and recommendations online (www.picscheme.org)

ISPE Baseline Guide 5 (Commissioning and Qualification)

ISPE Good Automated Manufacturing Practice (GAMP5)